Lars Otto Uttenthal

Directeur Technique/Scientifique/R&D chez PHARMA EQUITY GROUP A/S

79 ans

Health Technology

Consumer Services

Finance

Postes actifs de Lars Otto Uttenthal

Sociétés	Poste	Début	Fin
PHARMA EQUITY GROUP A/S	Directeur Technique/Scientifique/R&D	-	-
Bioporto Diagnostics A/S Bioporto Diagnostics A/S BiotechnologyHealth Technology Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013.	Directeur/Membre du Conseil	26/05/2010	-
AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	Directeur/Membre du Conseil	-	-

Sociétés	Poste	Début	Fin
BIOPORTO A/S	Directeur Technique/Scientifique/R&D	26/05/2010	-

University of Oxford

Doctorate Degree

Internationale

Opérationnelle

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
BIOPORTO A/S	Health Technology
PHARMA EQUITY GROUP A/S	Finance

Entreprise privées	2
Bioporto Diagnostics A/S Bioporto Diagnostics A/S BiotechnologyHealth Technology Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013.	Health Technology
AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	Health Technology